PROTEASOMINHIBITOREN

European patent · EP2178888 · In force

Register entry

Publication number
EP2178888
Application number
EP07811087
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 6, 2007
Published
Apr 28, 2010
Granted
Jul 4, 2012
Protection ends at the latest
Aug 5, 2027
Next annual fee due
Aug 31, 2027
IPC classes
C07F 5/02 (2006.01)
C07F 5/04 (2006.01)
C07K 5/06 (2006.01)
A61K 31/69 (2006.01)
A61K 38/05 (2006.01)
A61P 35/00 (2006.01)
A61P 29/00 (2006.01)
PCT application
PCT/US2007/017440 06.08.2007
PCT publication
WO2009/020448 12.02.2009
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Ixazomib

C02178888/01 · Medicine · Granted · Protection from Aug 6, 2027 to Feb 2, 2032

Authorisation 65959 (Swissmedic, Feb 3, 2017)

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. May 26, 2025

    Agent removed

    Representative
    PRAXI Intellectual Property SA, Via San Gottardo 15, 6900 Lugano (removed)

    Published in Swissreg on 26.05.2025

  4. May 26, 2025

    Transferred

    Owner
    Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA 02139, USA → Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645, Japan
    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 26.05.2025

  5. Apr 9, 2025

    Agent removed

    Representative
    Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano (removed)

    Published in Swissreg on 09.04.2025

  6. Apr 9, 2025

    Agent entered

    Representative
    PRAXI Intellectual Property SA, Via San Gottardo 15, 6900 Lugano

    Published in Swissreg on 09.04.2025

  7. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  8. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

5 earlier entries
  1. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  2. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  3. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  4. Aug 28, 2012

    Agent entered

    Representative
    Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano

    Published in Swissreg on 28.08.2012

  5. Jul 4, 2012

    Granted

    Published in Swissreg on 04.07.2012

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku, Osaka 540-8645, JP

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventor

OLHAVA, Edward, J.

Cambridge, MA 02139, US

DANCA, Miheala, D.

Mendham, NJ 07945, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.